vaccine policy

The U.S. Senate confirmed Dr. Erica Schwartz as the next director of the Centers for Disease Control and Prevention, with a 51-44 vote. The confirmation followed a July 2026 hearing where lawmakers questioned her on managing political interference in vaccine policy under the vaccine-skeptical agenda of the Department of Health and Human Services.

The U.S. Senate confirmed Dr. Erica Schwartz as the next director of the Centers for Disease Control and Prevention (CDC) with a 51-44 vote. The confirmation followed a tense July hearing over concerns about political interference in vaccine policy, and she received backing from Senate Health Committee chair Bill Cassidy despite initial reservations. Only one Democrat, Virginia’s Tim Kaine, supported the nomination.

The U.S. Senate Health, Education, Labor and Pensions Committee advanced Dr. Erica Schwartz’s nomination to lead the Centers for Disease Control and Prevention with a 13-10 vote. The confirmation hearing included bipartisan scrutiny over handling political influence in vaccine policy, and President Donald Trump nominated Schwartz in April.

The U.S. Senate Health, Education, Labor and Pensions Committee advanced Dr. Erica Schwartz's nomination to lead the Centers for Disease Control and Prevention with a 13-10 vote. The confirmation hearing included bipartisan concerns about political interference in vaccine policy, though all GOP members supported her bid and Sen. Tim Kaine was the sole Democrat to back her nomination.

The Trump administration is prioritizing religious freedom in health policies, which critics argue may impact LGBTQ+ healthcare, abortion access, and vaccine policy. A professor notes this approach could favor conservative Christianity and enable discrimination against LGBTQ individuals.

Health Secretary Robert F. Kennedy Jr. faces legal challenges over his efforts to limit vaccine eligibility and narrow immunization schedules, while a court case challenges childhood vaccine recommendations. Public trust in vaccines remains divided, with rising exemptions and political tensions influencing policy debates.